News Ex-NHS chief negotiator joins Newmarket Strategy Pharma veteran Blake Dark joins the healthcare and life sciences consultancy as senior partner.
News More digital mental health therapies backed for NHS use Online CBT programmes could help 40,000 people with depression and anxiety-related conditions.
News NICE okays neoadjuvant Opdivo in lung cancer BMS' checkpoint inhibitor is first to be given a green light for use before surgery in NSCLC.
News As pandemic abates, NICE issues new COVID drug guidance NICE says it is the first HTA to give guidance on the drugs outside of use during the pandemic.
News NICE won’t back AZ’s Evusheld for COVID prevention Blood Cancer UK calls for help for the 'forgotten 500,000' who can't be protected with vaccines
News NICE blocks wider use of Jardiance, Forxiga in heart failure Eli Lilly and Boehringer Ingelheim's Jardiance and AstraZeneca's Forxiga have not been recommended for NHS use as a treatment for symptomatic chronic heart failure (CHF) w
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
